HNF4A and gastric carcinoma: Post and colleagues showed that HNF4A is a highly useful marker for discriminating primary and metastatic breast carcinomas from gastric carcinomas, with a sensitivity of 99% and specificity of 100% [11], thus supporting the data of Koyama and colleagues; however, both studies examined only a few patients.